Aliada Therapeutics
Boston
About Aliada Therapeutics
Aliada Therapeutics is a biotechnology company developing novel therapies to treat central nervous system diseases. Its platform applies its technology to specific CNS target antibody binders and progress programs through preclinical evaluation to help medical professionals treat CNS diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $32.0M
- Funding stage: M&A
- Last round: Series Unknown (Dec 2022)
- Website: aliadatx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/aliada-therapeutics-51584 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.